339 related articles for article (PubMed ID: 28317038)
1. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
[TBL] [Abstract][Full Text] [Related]
2. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
[TBL] [Abstract][Full Text] [Related]
3. TAAR1 and Psychostimulant Addiction.
Liu J; Wu R; Li JX
Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
[TBL] [Abstract][Full Text] [Related]
4. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
5. Trace amine-associated receptor 1 and drug abuse.
Wu R; Liu J; Li JX
Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
[TBL] [Abstract][Full Text] [Related]
6. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.
Blum K; Liu Y; Wang W; Wang Y; Zhang Y; Oscar-Berman M; Smolen A; Febo M; Han D; Simpatico T; Cronjé FJ; Demetrovics Z; Gold MS
Postgrad Med; 2015 Mar; 127(2):232-41. PubMed ID: 25526228
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
[TBL] [Abstract][Full Text] [Related]
8. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
[TBL] [Abstract][Full Text] [Related]
10. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.
Liu JF; Seaman R; Siemian JN; Bhimani R; Johnson B; Zhang Y; Zhu Q; Hoener MC; Park J; Dietz DM; Li JX
Neuropsychopharmacology; 2018 Nov; 43(12):2435-2444. PubMed ID: 29472642
[TBL] [Abstract][Full Text] [Related]
11. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
Pei Y; Asif-Malik A; Canales JJ
Front Neurosci; 2016; 10():148. PubMed ID: 27092049
[TBL] [Abstract][Full Text] [Related]
12. Addiction Treatment in America: After Money or Aftercare?
Miller D; Miller M; Blum K; Badgaiyan RD; Febo M
J Reward Defic Syndr; 2015 Oct; 1(3):87-94. PubMed ID: 26835513
[TBL] [Abstract][Full Text] [Related]
13. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
14. Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.
Liu JF; Siemian JN; Seaman R; Zhang Y; Li JX
J Neurosci; 2017 Jan; 37(4):882-892. PubMed ID: 28123023
[TBL] [Abstract][Full Text] [Related]
15. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
16. Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine.
Sukhanov I; Dorofeikova M; Dolgorukova A; Dorotenko A; Gainetdinov RR
Front Pharmacol; 2018; 9():329. PubMed ID: 29681856
[TBL] [Abstract][Full Text] [Related]
17. TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg.
Liu JF; Li JX
Front Pharmacol; 2018; 9():279. PubMed ID: 29636691
[TBL] [Abstract][Full Text] [Related]
18. Trace amine-associated receptors and their ligands.
Zucchi R; Chiellini G; Scanlan TS; Grandy DK
Br J Pharmacol; 2006 Dec; 149(8):967-78. PubMed ID: 17088868
[TBL] [Abstract][Full Text] [Related]
19. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
20. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
